Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Return on Invested Capital [ROIC] (2026)

Updated

Abeona Therapeutics (ABEO) recorded Return on Invested Capital [ROIC] of -51.55% in Q3 2026, down 7.67 percentage points from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Return on Invested Capital [ROIC] (2026) Analysis & Trends

For FY2025, Abeona Therapeutics reported Return on Invested Capital [ROIC] of -73.75%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.57%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 24.28%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.52%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 22.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.11%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 12.34%
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -51.55%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -51.55%
Jun 30, 2026 -43.88%
API Access

Abeona Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ABEO&period=max&api_key=YOUR_API_KEY